BIOL 4376 Chapter Notes - Chapter 9: Prokaryotic Small Ribosomal Subunit, Upper Respiratory Tract Infection, Bioavailability
Document Summary
Pcn-resistant strains), enterococci (including vre: aes, potential for increased bp w tyramine-containing foods, sympathomimetics, myelosuppression, particularly thrombocytopenia, main uses: mrsa or vre infections, resistance due to: altered target site. Nitroimidazoles: metronidazole, moa: interacts w dna leading to breakage, excellent bioavailability, spectrum: anaerobes, protozoa, adverse effects, gi n/v/d, cns dizziness, neurophaties, seizures, disulfuram-like reaction, role in therapy, anaerobic infections: c. diff colitis, some parasitic infections. Elderly: mental status change: absorption reduced w multivalent cations. Have very high resistance in other areas: pneumocystis jiroveci, toxoplasma gondii, adverse effects, hypersensitivity (sulfamethoxazole, hyperkalemia, bone marrow suppression (trimethoprim, renal dysfunction, main uses, utis, ssti, urtis, opportunistic infections. M e t r o n id - L e v o m o x i a z o le. C ip r o d e la f lo x t r im e t h. A n a e r : b e s.